Hospital day care follow-up
OtherRegular follow up every month in hospital day care
NCT Number: NCT04604873
The main objective is to show the impact on the quality of life (QoL) for adults patients with advanced cancer managed in day hospital of integrated palliative care of cancer center (HDJ-SPI).
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Institut Bergonie, Bordeaux, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Regular follow up every month in hospital day care
Time frame: 12 months
Analyse impact of hospital day care in integrated palliative care department on quality of life of adult patients with advanced stage cancer
Outcome shall be evaluated by assessing Survival without quality of life deterioration,measured by EORTC QLQ-C30 scale with monthly evaluation targeting three dimensions :
global quality of life/ fatigue/ patient emotional state
Institut Curie
Other
The Integrated Support and Palliative in Cancer Day-care Hospital for Patients With Advanced Cancers: Impact on Quality of Life, Care Pathways and Support for Caregivers
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05200572
Cancer, Advanced, Cognition Disorders
Rochester, New York, United States
View Trial DetailsNCT04028479
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Idaho Falls, Idaho, United States
View Trial DetailsNCT01380184
Cancer, Advanced, Disease Attributes
View Trial DetailsNCT00750178
Cancer, Advanced, Neoplasms
View Trial Details